CVS HEALTH (AND SUBSIDIARIES) for CVS HEALTH (AND SUBSIDIARIES)
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Veterans VET
Veterans healthcare, no specific legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHANNON PENBERTHY | — |
| BILLY RAINES | — |
| MELISSA SCHULMAN | — |
Medicare/Medicaid MMM
Medicare/Medicaid-Issues related to plan design, reimbursement, audit and cost savings proposals. Issues related to Part D prescriber enrollment. HR 793 - Ensuring Seniors Access to Local Pharmacies Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BROOKS New | — |
| SHANNON PENBERTHY New | — |
| MARISSA SCHLAIFER | — |
| ANN WALKER | — |
Health Issues HCR
Issues related to smoking cessation, Medicare Part D and anti-PBM legislation. Other issues include health care delivery system reforms including telehealth, chronic care, Innovation Initiative & health IT, cost containment and medication adherence. HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act HR 2029-Consolidated Appropriations Act of 2016 S 2141-Transparent Ratings on Usability & Security to Transform Information Technology H.R. 2712,Commonsense Reporting and Verification Act of 2015 S. 1996, Commonsense Reporting Act of 2015
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BROOKS New | — |
| BILLY RAINES | — |
| MARISSA SCHLAIFER | — |
| MELISSA SCHULMAN | — |
| ANN WALKER | — |
Pharmacy PHA
Issues related to prescription drug abuse, preferred pharmacy networks, pharmacist provider status, drug pricing and Tricare. Issues related to biosimilars, FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S 776 - Medication Therapy Management Empowerment Act of 2015 HR 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 HR 6-Stopping Medication Abuse and Protecting Seniors Act of 2015 S 1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 HR 1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S 480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S. 524-Comprehensive Addiction and Recovery Act HR 4909-National Defense Authorization Act S 2943--National Defense Authorization Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BROOKS New | — |
| SHANNON PENBERTHY New | — |
| BILLY RAINES | — |
| MARISSA SCHLAIFER | — |
| MELISSA SCHULMAN | — |
| ANN WALKER | — |
Taxation/Internal Revenue Code TAX
Issues related to restructuring of corporate tax rates. HR4770-To amend the Internal Revenue Code of 1986 to provide appropriate rules for the application of the deduction for income attributable to domestic production activities with respect to certain contract manufacturing or production arrangements
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILLY RAINES | — |
| MELISSA SCHULMAN | — |
| ANN WALKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.